Literature DB >> 23731162

Phosphatidylethanol: the potential role in further evaluating low positive urinary ethyl glucuronide and ethyl sulfate results.

Gregory E Skipper1, Natasha Thon, Robert L Dupont, Louis Baxter, Friedrich M Wurst.   

Abstract

BACKGROUND: Whereas urinary ethyl glucuronide (EtG) levels above 1,000 ng/ml reflect with a high probability ethanol (EtOH) consumption, levels below this cutoff are difficult to interpret as both extraneous (nonbeverage) EtOH exposure, recent drinking, and more distant high EtOH intake (several days ago) might yield similar results. This might be of particular relevance in medico-legal cases. To overcome this dilemma, phosphatidylethanol (PEth) might be a promising marker, because blood PEth is only positive following significant alcohol use. The aim of our study was therefore to employ PEth as a marker to differentiate between the different conditions.
METHODS: Subjects included were 252 participants in monitoring with the Alabama Physician Health Program. All subjects testing positive for EtG and/or ethyl sulfate (EtS) who denied drinking after routine supportive confrontation were subject to information about PEth testing. If they still denied drinking, PEth testing was performed and the result communicated. EtG, EtS, and PEth testing was performed in a commercial laboratory using liquid chromatography tandem mass spectrometry methods.
RESULTS: Of a total of 18 subjects who tested positive for EtG and/or EtS, 10 denied drinking. Of the 7 who denied drinking after PEth explanation, in 5 cases, their claim was supported by a negative PEth result. In 2 cases, a positive PEth result was in contrast to their claim.
CONCLUSIONS: PEth results in combination with previous low positive EtG/EtS results allow differentiating between innocent/extraneous exposure and drinking. Negative PEth testing following low positive EtG/EtS results helps to further elucidate the findings and support the claim of the patient of recent alcohol abstinence. Positive PEth testing following positive EtG/EtS results confirms recent drinking.
Copyright © 2013 by the Research Society on Alcoholism.

Entities:  

Keywords:  Ethyl Glucuronide; Ethyl Sulfate; Monitoring; Phosphatidylethanol; Physician Health Program

Mesh:

Substances:

Year:  2013        PMID: 23731162     DOI: 10.1111/acer.12121

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  5 in total

Review 1.  Return to Alcohol Use After Liver Transplant: Patterns and Surveillance.

Authors:  Brian P Lee; Norah A Terrault
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-01-02

2.  Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease.

Authors:  Scott H Stewart; David G Koch; Ira R Willner; Raymond F Anton; Adrian Reuben
Journal:  Alcohol Clin Exp Res       Date:  2014-05-21       Impact factor: 3.455

3.  Comparison of Traditional and Novel Self-Report Measures to an Alcohol Biomarker for Quantifying Alcohol Consumption Among HIV-Infected Adults in Sub-Saharan Africa.

Authors:  Stephen B Asiimwe; Robin Fatch; Nneka I Emenyonu; Winnie R Muyindike; Allen Kekibiina; Glenn-Milo Santos; Thomas K Greenfield; Judith A Hahn
Journal:  Alcohol Clin Exp Res       Date:  2015-07-04       Impact factor: 3.455

Review 4.  Diagnosis of alcoholic liver disease.

Authors:  Cara Torruellas; Samuel W French; Valentina Medici
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 5.  Biomolecules and Biomarkers Used in Diagnosis of Alcohol Drinking and in Monitoring Therapeutic Interventions.

Authors:  Radu M Nanau; Manuela G Neuman
Journal:  Biomolecules       Date:  2015-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.